Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled? - Wikidata - awgldk - TriplyDB

Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled?

Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled?

http://www.wikidata.org/entity/Q26771340

about

Surgical Aspects of Ovarian Tissue Removal and Ovarian Tissue Transplantation for Fertility Preservation Twenty-five-year-old Woman with Bilateral Borderline Ovarian Tumour Desiring to Preserve Fertility - Case Report and Literature Review on the Current State of Fertility Preservation in Women with Borderline Ovarian Tumours.Preservation of Fertility or Ovarian Function in Patients with Breast Cancer or Gynecologic and Internal Malignancies.Operative techniques and complications of extraction and transplantation of ovarian tissue: the Erlangen experience.Pregnancy in the liver transplant recipient.Repetitive Maturation of Oocytes From Non-Stimulated Xenografted Ovarian Tissue From a Prepubertal Patient Indicating the Independence of Human Ovarian Tissue.

P2860

Q28071283-9FDAF14E-A69A-4D97-A32E-A19DFF870894 Q37441942-B6F1D8B3-0E55-4B83-8692-567EF045FEE3 Q38606467-7B9ADE3C-6CA3-44E5-9775-56F15D151A01 Q38757529-884A94E5-9272-4E42-9A50-0EEC9BF082EA Q38838738-2B4F0C32-85AD-43A2-9DCB-08A19069378E Q47119993-200076AE-3293-43DC-A01C-3819A38C4D9A

P2860

Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled?

http://www.wikidata.org/entity/Q26771340

description

2015 nî lūn-bûn

@nan

2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled?

@ast

Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled?

@en

Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled?

@nl

type

label

Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled?

@ast

Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled?

@en

Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled?

@nl

prefLabel

Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled?

@ast

Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled?

@en

Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled?

@nl

P1433

Q26771340-43FE2349-8132-4A95-8903-6BDCEE22AB0F

P1476

Q26771340-A0AB5BC3-CEDA-4DC2-B7E9-E315DE88C63D

P2093

Q26771340-07FD1125-005D-4690-85F5-9FDA4E3F015A

Q26771340-192EE545-93A7-4754-9766-B437C5949D83

Q26771340-4B9ED07E-B92D-457A-A386-026927604A7A

Q26771340-51C5CF2A-666D-4EF5-949D-00A8831D3738

Q26771340-E63845DA-1626-461A-95AB-7435308EB291

P2860

Q26771340-0364F31A-D2E5-489F-A269-B2AB7CE86A40

Q26771340-04CB2021-C5D5-4C11-8DC4-682D0819FFF5

Q26771340-0A08D424-6022-4276-A512-73301F695B0B

Q26771340-102F5CB0-474A-40B2-A98F-ABAD53E059DB

Q26771340-1BC7A479-99DB-43E6-8FDE-64F901CB7027

Q26771340-20BB31BE-A5AF-4D26-88DA-4927B8DE3303

Q26771340-251DE342-3313-4BC6-B5E6-3AC65F706D88

Q26771340-2B6D8641-4EBD-48AD-BA56-D0AC68FD4415

Q26771340-2E32113F-144A-4313-919C-7EF2B171CB10

Q26771340-3798175C-7941-44F4-BCE3-CBF96E006A52

P304

Q26771340-4C785FFA-CC36-4DC3-A5D2-40AFF207E2B2

P31

Q26771340-405BB90C-9942-443C-905C-11758F62DF42

P356

Q26771340-C18D1FB6-E0F5-4ED5-96E0-E1EADCF29312

P433

Q26771340-C80B0A72-832E-4C35-8756-44215E141B92

P478

Q26771340-4D9EB1DD-9518-4FF3-A856-CE313BF3C380

P50

Q26771340-27E10196-290C-4536-B6D1-0C062C3A2F94

P577

Q26771340-1AE0D92B-29FC-4117-9FF7-EC8ECF5A2DCC

P698

Q26771340-B93E19CE-314D-4A10-83A3-07B539C25A64

P921

Q26771340-D3829B3A-1DC3-4460-BA02-88C34F7E7B47

P932

Q26771340-D6C90E86-F411-4F86-BFDF-71ABF8EAD3FE

P356

P1433

Geburtshilfe und Frauenheilkunde: Ergebnisse der Forschung für die Praxis

P1476

Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled?

@en

P2093

I Hoffmann

http://www.w3.org/2001/XMLSchema#string

K Heusinger

http://www.w3.org/2001/XMLSchema#string

L Lotz

http://www.w3.org/2001/XMLSchema#string

R Dittrich

http://www.w3.org/2001/XMLSchema#string

S Findeklee

http://www.w3.org/2001/XMLSchema#string

P2860

Fertility sparing treatment in borderline ovarian tumours

Entry Complications in Laparoscopic Surgery

A critical appraisal of cryopreservation (slow cooling versus vitrification) of human oocytes and embryos

GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data.

Doxorubicin-induced ovarian toxicity.

Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update.

Borderline epithelial tumors of the ovary: Experience of 55 patients.

The prevention of ovarian hyperstimulation syndrome.

Impact of cancer treatment on uterine function.

Female fertility after cytotoxic therapy--protection of ovarian function during chemotherapy of malignant and non-malignant diseases.

P304

1243-1249

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1055/S-0035-1558184

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P50

Matthias W. Beckmann

P577

2015-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26726265

http://www.w3.org/2001/XMLSchema#string

P921

obstetrics and gynaecology

P932

4686370

http://www.w3.org/2001/XMLSchema#string